Lupin Limited Unit 1

Form 483 issued December 4, 2018 · Madhya. Pradesh, India

Inspection
Nov 26 – Dec 4, 2018
Observations
10
Pages
25
FEI number
3002807511

In short: On December 4, 2018, FDA issued a Form 483 with 10 observations to Lupin Limited Unit 1 in Madhya. Pradesh, Madhya Pradesh (FEI 3002807511) after an inspection that ran Nov 26 – Dec 4, 2018. The investigators were Christopher Keating, June P. Page and Pratik S. Upadhyay. Most observations concern production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.113 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures for aseptic process (media fill) simulations, performed in the sterile APT manufacturing…

9 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lupin Limited Unit 1?

FDA listed 10 observations on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Lupin Limited Unit 1?

Christopher Keating, June P. Page and Pratik S. Upadhyay are named on this Form 483, for the inspection of Nov 26 – Dec 4, 2018. Each investigator has a profile showing what they cite most.

When was Lupin Limited Unit 1 inspected by FDA?

The inspection ran Nov 26 – Dec 4, 2018, and the Form 483 is dated December 4, 2018.

How do I get the full Form 483 for Lupin Limited Unit 1?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free